openPR Logo
Press release

First Indian Pharma Company successfully goes live with electronic MES using Werum’s PAS-X

01-12-2012 06:43 AM CET | IT, New Media & Software

Press release from: Werum Software & Systems AG

Dr. Reddy’s site in Hyderabad, India

Dr. Reddy’s site in Hyderabad, India

First Indian Pharma Company successfully goes live with electronic MES using Werum’s PAS-X
Dr. Reddy’s Laboratories Ltd. completes first implementation phase of Werum’s standard Manufacturing Execution System at Hyderabad site

Lueneburg/Germany, 11 January 2012 – The pharmaceutical major Dr. Reddy’s is the first Indian company to improve its manufacturing processes by installing an electronic PAS-X Manufacturing Execution System (MES). Dr. Reddy’s opted for Werum’s MES PAS-X to help enhance the quality and compliance and to optimize the efficiency and productivity of its pharmaceutical shop floor processes.

Implementing PAS-X forms part of Dr. Reddy’s expansion strategy. The first step, now successfully completed, involved installing PAS-X at one of the company's FDA and MHRA approved production facilities at Bachupally in Hyderabad.

In its first step, the PAS-X handles and controls the Warehouse Management System, such as receiving, sampling and storing of materials. It also carries out Weighing & Dispensing and Equipment Management operations.

Using mobile terminals, PAS-X coordinates the barcode-controlled process for material tracking and tracing of containers as they travel from the warehouse to the dispensing area. An automated interface allows PAS-X to communicate directly with Dr. Reddy’s ERP (SAP).

The project is being carried out by a team of experienced experts at Werum’s Asia Support Centre with Dr. Reddy’s Internal Core Team.

With over 40 years of software development experience, Werum Software & Systems AG is known worldwide for partnering with its global customers to create state-of-the-art software products and solutions. Internationally networked teams of top experts develop software solutions for corporate groups known the world over. Werum is an internationally leading supplier of Manufacturing Execution Systems (MES) for the pharmaceutical and biopharmaceutical industries. Its successful and well-established MES product PAS-X is used by 16 of the world’s top 30 pharmaceutical and biotech companies in more than 550 installations. Founded in 1969, the IT company employs about 450 people at its headquarters in Lueneburg, Germany, and at eight other locations in Germany, France, the United States, Japan, and Singapore. For more information take a look at our websites at www.werum.com and www.pas-x.com.

Dirk Ebbecke
Director Corporate Communications
Werum Software & Systems AG
Wulf-Werum-Strasse 3
21337 Lueneburg, Germany
Tel. +49 4131 8900-689
Fax +49 4131 8900-20
dirk.ebbecke@werum.com

For further information, visit Werum’s press center at www.press.werum.com.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release First Indian Pharma Company successfully goes live with electronic MES using Werum’s PAS-X here

News-ID: 206709 • Views:

More Releases from Werum Software & Systems AG

Research Made Easy
With their web-based data management system DSHIP the German-based company Werum Software & Systems supports maritime research on board of research vessels all over the world. The Instagram profile of the current climate research expedition MOSAiC in the North Polar Sea shows straightaway: research work on the high seas may be really fascinating, but it also is extremely laborious, fragmented and highly complex. As they depend on the various environmental conditions
Werum’s
Werum’s "PAS-X Reports & Labels" Content Packages significantly reduce MES imp …
Werum’s "PAS-X Reports & Labels" Content Packages significantly reduce MES implementation times Best practice consulting services and “Out of the Box”-templates for GMP-compliant reports and labels Lueneburg, Germany, 29 January 2014 – By providing "PAS-X Reports & Labels" Content Packages, Werum Software & Systems now offers an even broader range of pre-configured reports and labels along with the associated comprehensive consulting services to its customers. These packages are based on best practices
Werum accelerates MBR creation by providing
Werum accelerates MBR creation by providing "PAS-X MBR Design Elements" Content …
Werum accelerates MBR creation by providing "PAS-X MBR Design Elements" Content Packages New "PAS-X MBR Design Elements" Content Packages based on industry best practice / process-specific and fast MBR creation for pharmaceutical production Lueneburg, Germany, 28 November 2013 – In order for pharma and biotech customers to implement PAS-X MES projects even faster and more easily, Werum Software & Systems expands its PAS-X Content Packages offering further: New on the market are
Werum equips research vessel Mya II of Alfred Wegener Institute with DSHIP software
Werum equips research vessel Mya II of Alfred Wegener Institute with DSHIP softw …
Werum equips research vessel Mya II of Alfred Wegener Institute with DSHIP software AWI puts new RV Mya II into service / Werum's data management system DSHIP ensures acquisition, archiving and evaluation of measurement data Lueneburg, Germany, 23 October 2013 – The new RV Mya II, which has only recently been delivered to the German Alfred Wegener Institute, Helmholtz Center for Polar and Marine Research (AWI), has been equipped by Werum Software

All 5 Releases


More Releases for Reddy’s

Clopidogrel Market 2025 | Pfizer, Dr Reddy’s, Apotex Corp, Roxane Laboratories …
Global Clopidogrel Market: Snapshot Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are
Dr. Vishnu Reddy’s Clinic announces HealthCare360 to deliver a comprehensive p …
Healthcare experience has seen a surge as teleconsultations follow the long-pending telemedicine guidelines which were recently issued by the ministry of health. This launch will exponentially increase the score of telemedicine space, both patients and doctors have relied on the sector. Hyderabad, India (07 July 2020) - Dr. Vishnu Reddy’s Clinic, a Hyderabad based renowned ENT & Facial Plastic clinic today announced the launch of, brand new healthcare experience for their
Clopidogrel Market Global Forecasts upto 2017-2025 | Pfizer, Dr Reddy’s, Apote …
Global Clopidogrel Market: Snapshot Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are
Clopidogrel Market Key Contributors 2017-2025 : Pfizer, Dr Reddy’s, Apotex Cor …
Global Clopidogrel Market: Snapshot Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are
Clopidogrel Market - Top leading manufacturers 2025 | Pfizer, Dr Reddy’s
Global Clopidogrel Market: Snapshot Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are
Survey: Atorvastatin Market Size 2018-2025 Pfizer, Morepen, Topfond, Dr. Reddy …
Atorvastatin Market Research 2018 A market study "Global Atorvastatin Market" examines the performance of the Atorvastatin market 2018. It encloses an in-depth Research of the Atorvastatin market state and the competitive landscape Globally. This report analyzes the potential of Atorvastatin market in the present and the future prospects from various angles in detail. The Global Atorvastatin Market 2018 report includes Atorvastatin market Revenue, market Share, Atorvastatin industry volume, market Trends, Atorvastatin Growth